Literature DB >> 9746804

Increased levels of endothelin-1 in plasma of sickle cell anemia patients.

A C Rybicki, L J Benjamin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9746804

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  37 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

2.  Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Authors:  Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-02-17       Impact factor: 6.998

3.  Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.

Authors:  Brian T Kalish; Alessandro Matte; Immacolata Andolfo; Achille Iolascon; Olga Weinberg; Alessandra Ghigo; James Cimino; Angela Siciliano; Emilio Hirsch; Enrica Federti; Mark Puder; Carlo Brugnara; Lucia De Franceschi
Journal:  Haematologica       Date:  2015-05-01       Impact factor: 9.941

Review 4.  Pulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.

Authors:  Raymond L Benza
Journal:  Lung       Date:  2008-05-10       Impact factor: 2.584

5.  Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

Review 6.  New insights into the pathophysiology and development of novel therapies for sickle cell disease.

Authors:  Scott Moerdler; Deepa Manwani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

7.  Effects of nitric oxide and its congeners on sickle red blood cell deformability.

Authors:  Andrea M Belanger; Christian Keggi; Tamir Kanias; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Transfusion       Date:  2015-04-23       Impact factor: 3.157

8.  Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Authors:  Caterina P Minniti; Roberto F Machado; Wynona A Coles; Vandana Sachdev; Mark T Gladwin; Gregory J Kato
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

9.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

10.  Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Authors:  Nathalie Sabaa; Lucia de Franceschi; Philippe Bonnin; Yves Castier; Giorgio Malpeli; Haythem Debbabi; Ariane Galaup; Micheline Maier-Redelsperger; Sophie Vandermeersch; Aldo Scarpa; Anne Janin; Bernard Levy; Robert Girot; Yves Beuzard; Christophe Leboeuf; Annie Henri; Stéphane Germain; Jean-Claude Dussaule; Pierre-Louis Tharaux
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.